{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:57:49Z","timestamp":1773712669230,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.yebeh.2013.08.024","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T13:15:18Z","timestamp":1379942118000},"page":"281-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities"],"prefix":"10.1016","volume":"29","author":[{"given":"Andrea E.","family":"Cavanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Seri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2013.08.024_bb0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1528-1157.1985.tb05408.x","article-title":"Zonisamide in epilepsy: a pilot study","volume":"26","author":"Wilensky","year":"1985","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/wnf.0b013e3180413d7d","article-title":"Clinical pharmacology and mechanism of action of zonisamide","volume":"30","author":"Biton","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/01.wnl.0000250236.75053.16","article-title":"Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study","volume":"68","author":"Murata","year":"2007","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2013.08.024_bb0020","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.eplepsyres.2005.11.006","article-title":"Practical prescribing and long-term efficacy and safety of zonisamide","volume":"68","author":"Leppik","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0033-3182(90)72198-6","article-title":"Zonisamide induced mania","volume":"2","author":"Charles","year":"1990","journal-title":"Psychosomatics"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/seiz.1999.0368","article-title":"Psychotic episodes during zonisamide treatment","volume":"9","author":"Miyamoto","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1176\/appi.psy.47.1.68","article-title":"Zonisamide-induced suicidal ideation","volume":"47","author":"Mago","year":"2006","journal-title":"Psychosomatics"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/WNL.0b013e3181eccfb5","article-title":"Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case\u2013control study","volume":"75","author":"White","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2006.08.008","article-title":"Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy","volume":"10","author":"Weintraub","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0050","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1528-1157.1996.tb00610.x","article-title":"The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale","volume":"37","author":"O'Donoghue","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0055","series-title":"Text revision (DSM-IV-TR)","article-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/JCP.0b013e318253a186","article-title":"Behavioral adverse effects of antiepileptic drugs in epilepsy","volume":"32","author":"Eddy","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11599780-000000000-00000","article-title":"Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations","volume":"26","author":"Piedad","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/1756285611417920","article-title":"The cognitive impact of antiepileptic drugs","volume":"4","author":"Eddy","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0075","first-page":"83","article-title":"Depression in women with epilepsy: clinical and neurobiological aspects","volume":"24","author":"Cavanna","year":"2009","journal-title":"Funct Neurol"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yebeh.2005.07.003","article-title":"Obsessionality, obsessive\u2013compulsive disorder, and temporal lobe epilepsy","volume":"7","author":"Monaco","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/appi.neuropsych.20.2.223","article-title":"Phenomenology of obsessive compulsive disorder in patients with temporal lobe epilepsy or Tourette syndrome","volume":"20","author":"Mula","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/seiz.2000.0405","article-title":"Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables","volume":"9","author":"Trimble","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0100","first-page":"191","article-title":"The prevalence of psychiatric disorders in epilepsy: a critical review of the evidence","volume":"25","author":"Jones","year":"2011","journal-title":"Funct Neurol"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0105","series-title":"Zonegran: summary of product characteristics","author":"Eisai Ltd.","year":"2010"},{"key":"10.1016\/j.yebeh.2013.08.024_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0920-1211(93)90021-X","article-title":"Efficacy and safety of zonisamide: results of a multicenter study","volume":"14","author":"Leppik","year":"1993","journal-title":"Epilepsy Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505013004290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505013004290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T17:27:57Z","timestamp":1646587677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505013004290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1525505013004290"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2013.08.024","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2013.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}